Biosimilars Report Bolsters IGBA’s Calls To Streamline Development Process

IPRP Biosimilars Working Group Urges Reassessment Of Comparative Efficacy Studies

 
• By Dave Wallace
  
IGBA logo
The IGBA wants a more streamlined approach to biosimilar development • Source: IGBA

More from Biosimilars

More from Products